Mindfulness for Better Sleep and Comfort in Cancer Patients
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
This project offers a mindfulness program to help patients with blood cancers sleep better and feel more comfortable during and after their hospital stays for chemotherapy.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11135362 on NIH RePORTER |
What this research studies
Patients with life-threatening blood cancers often struggle with insomnia, fatigue, distress, and pain, especially during and after high-dose chemotherapy in the hospital. We are testing a program called Nite2Day+ that uses mindfulness meditations and behavioral strategies to improve sleep and related symptoms. This program will be delivered through a mobile app while patients are in the hospital, and it aims to help them accept the challenges of their inpatient treatment. We hope this approach will make a significant difference in how patients feel during a very difficult time.
Who could benefit from this research
Good fit: Ideal candidates are patients with hematologic cancer who are experiencing insomnia symptoms during hospitalization for high-dose chemotherapy.
Not a fit: Patients who do not have hematologic cancer or are not experiencing insomnia during inpatient chemotherapy may not receive direct benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could provide a valuable tool for blood cancer patients to manage sleep problems, fatigue, distress, and pain, improving their overall well-being during and after treatment.
How similar studies have performed: A previous version of this program, Nite2Day, showed strong feasibility, acceptability, and significant improvements in insomnia and other symptoms for patients after hospital discharge.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Fisher, Hannah M — Duke University
- Study coordinator: Fisher, Hannah M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.